Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Vinderup Fysioterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.4%   Bankruptcy risk   2.0% 3.2% 2.1% 2.0% 1.7% 2.2% 9.9% 6.9%   Credit score (0-100)   70 57 69 68 72 66 3 3   Credit rating   A BBB A A A BBB BB BBB   Credit limit (kDKK)   0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,733 1,384 1,785 2,318 2,412 2,263 0.0 0.0   EBITDA   756 690 738 877 1,012 545 0.0 0.0   EBIT   386 375 455 559 703 234 0.0 0.0   Pre-tax profit (PTP)   284.3 300.8 338.5 442.2 572.2 152.9 0.0 0.0   Net earnings   224.0 240.7 267.9 338.0 439.4 111.9 0.0 0.0   Pre-tax profit without non-rec. items   284 301 338 442 572 153 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   157 62.2 253 1,824 1,735 1,709 0.0 0.0   Shareholders equity total   425 -114 154 492 932 643 193 193   Interest-bearing liabilities   2,423 2,612 2,484 2,964 2,697 2,609 962 962   Balance sheet total (assets)   3,237 2,960 3,226 4,290 4,445 4,226 1,155 1,155   Net Debt   2,165 2,612 2,484 2,960 2,697 2,609 962 962     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,733 1,384 1,785 2,318 2,412 2,263 0.0 0.0   Gross profit growth   25.2% -20.2% 29.0% 29.8% 4.1% -6.2% -100.0% 0.0%   Employees   4 2 2 3 4 4 0 0   Employee growth %   0.0% -50.0% 0.0% 50.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,237 2,960 3,226 4,290 4,445 4,226 1,155 1,155   Balance sheet change%   -5.8% -8.6% 9.0% 33.0% 3.6% -4.9% -72.7% 0.0%   Added value   386.3 374.8 455.5 558.5 703.1 234.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -739 -630 -311 1,032 -618 -557 -1,709 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.3% 27.1% 25.5% 24.1% 29.1% 10.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.9% 13.1% 13.7% 15.1% 16.5% 5.9% 0.0% 0.0%   ROI %   13.4% 13.7% 14.5% 16.7% 18.8% 6.9% 0.0% 0.0%   ROE %   56.8% 14.2% 17.2% 104.6% 61.7% 14.2% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   13.1% -3.7% 4.8% 11.5% 21.0% 15.2% 16.7% 16.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   286.4% 378.7% 336.7% 337.7% 266.4% 478.3% 0.0% 0.0%   Gearing %   570.8% -2,296.4% 1,611.3% 602.3% 289.5% 405.4% 497.0% 497.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.6% 4.5% 3.6% 4.6% 5.2% 3.9% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.6 1.1 1.5 0.9 0.7 0.6 0.0 0.0   Current Ratio   1.6 1.1 1.6 0.9 0.8 0.6 0.0 0.0   Cash and cash equivalent   258.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   228.0 76.1 349.5 -52.8 -418.1 -840.4 -480.8 -480.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   97 187 228 186 176 59 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   189 345 369 292 253 136 0 0   EBIT / employee   97 187 228 186 176 59 0 0   Net earnings / employee   56 120 134 113 110 28 0 0